JP2018517787A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018517787A5 JP2018517787A5 JP2018518567A JP2018518567A JP2018517787A5 JP 2018517787 A5 JP2018517787 A5 JP 2018517787A5 JP 2018518567 A JP2018518567 A JP 2018518567A JP 2018518567 A JP2018518567 A JP 2018518567A JP 2018517787 A5 JP2018517787 A5 JP 2018517787A5
- Authority
- JP
- Japan
- Prior art keywords
- effective amount
- vitamin
- magnesium
- combination
- taurine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 48
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 25
- 239000011777 magnesium Substances 0.000 claims 25
- 229910052749 magnesium Inorganic materials 0.000 claims 25
- 229960003080 taurine Drugs 0.000 claims 24
- 208000002874 Acne Vulgaris Diseases 0.000 claims 20
- 206010000496 acne Diseases 0.000 claims 20
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 8
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims 8
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims 8
- 239000003795 chemical substances by application Substances 0.000 claims 6
- 235000015872 dietary supplement Nutrition 0.000 claims 6
- 238000011282 treatment Methods 0.000 claims 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 4
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 4
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims 4
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims 4
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims 4
- 229930003451 Vitamin B1 Natural products 0.000 claims 4
- 229930003471 Vitamin B2 Natural products 0.000 claims 4
- 229930003537 Vitamin B3 Natural products 0.000 claims 4
- 229930003571 Vitamin B5 Natural products 0.000 claims 4
- 229930003268 Vitamin C Natural products 0.000 claims 4
- 229930003316 Vitamin D Natural products 0.000 claims 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims 4
- 229930003427 Vitamin E Natural products 0.000 claims 4
- 229930003448 Vitamin K Natural products 0.000 claims 4
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims 4
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims 4
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims 4
- 239000011575 calcium Substances 0.000 claims 4
- 235000001465 calcium Nutrition 0.000 claims 4
- 229960005069 calcium Drugs 0.000 claims 4
- 229910052791 calcium Inorganic materials 0.000 claims 4
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims 4
- 229960002079 calcium pantothenate Drugs 0.000 claims 4
- 239000002775 capsule Substances 0.000 claims 4
- 229960001231 choline Drugs 0.000 claims 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims 4
- 229940108928 copper Drugs 0.000 claims 4
- 229910052802 copper Inorganic materials 0.000 claims 4
- 239000010949 copper Substances 0.000 claims 4
- 229960000304 folic acid Drugs 0.000 claims 4
- 235000019152 folic acid Nutrition 0.000 claims 4
- 239000011724 folic acid Substances 0.000 claims 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 4
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 claims 4
- 229960000367 inositol Drugs 0.000 claims 4
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims 4
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 4
- 229960003284 iron Drugs 0.000 claims 4
- 229910052742 iron Inorganic materials 0.000 claims 4
- 235000012680 lutein Nutrition 0.000 claims 4
- 229960005375 lutein Drugs 0.000 claims 4
- 239000001656 lutein Substances 0.000 claims 4
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims 4
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims 4
- 235000012661 lycopene Nutrition 0.000 claims 4
- 229960004999 lycopene Drugs 0.000 claims 4
- 239000001751 lycopene Substances 0.000 claims 4
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims 4
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims 4
- 239000011785 micronutrient Substances 0.000 claims 4
- 235000013369 micronutrients Nutrition 0.000 claims 4
- 229960003512 nicotinic acid Drugs 0.000 claims 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 4
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims 4
- 229940012843 omega-3 fatty acid Drugs 0.000 claims 4
- 239000006014 omega-3 oil Substances 0.000 claims 4
- 239000011574 phosphorus Substances 0.000 claims 4
- 229910052698 phosphorus Inorganic materials 0.000 claims 4
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims 4
- 239000011591 potassium Substances 0.000 claims 4
- 229910052700 potassium Inorganic materials 0.000 claims 4
- 239000000843 powder Substances 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims 4
- 229960002477 riboflavin Drugs 0.000 claims 4
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims 4
- 239000011669 selenium Substances 0.000 claims 4
- 229910052711 selenium Inorganic materials 0.000 claims 4
- 229960003495 thiamine Drugs 0.000 claims 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims 4
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims 4
- 235000019155 vitamin A Nutrition 0.000 claims 4
- 239000011719 vitamin A Substances 0.000 claims 4
- 235000010374 vitamin B1 Nutrition 0.000 claims 4
- 239000011691 vitamin B1 Substances 0.000 claims 4
- 235000019164 vitamin B2 Nutrition 0.000 claims 4
- 239000011716 vitamin B2 Substances 0.000 claims 4
- 235000019160 vitamin B3 Nutrition 0.000 claims 4
- 239000011708 vitamin B3 Substances 0.000 claims 4
- 239000011675 vitamin B5 Substances 0.000 claims 4
- 235000009492 vitamin B5 Nutrition 0.000 claims 4
- 235000019154 vitamin C Nutrition 0.000 claims 4
- 239000011718 vitamin C Substances 0.000 claims 4
- 235000019166 vitamin D Nutrition 0.000 claims 4
- 239000011710 vitamin D Substances 0.000 claims 4
- 150000003710 vitamin D derivatives Chemical class 0.000 claims 4
- 235000019165 vitamin E Nutrition 0.000 claims 4
- 239000011709 vitamin E Substances 0.000 claims 4
- 229940046009 vitamin E Drugs 0.000 claims 4
- 235000019168 vitamin K Nutrition 0.000 claims 4
- 239000011712 vitamin K Substances 0.000 claims 4
- 150000003721 vitamin K derivatives Chemical class 0.000 claims 4
- 229940045997 vitamin a Drugs 0.000 claims 4
- 229940046008 vitamin d Drugs 0.000 claims 4
- 229940046010 vitamin k Drugs 0.000 claims 4
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims 4
- 235000010930 zeaxanthin Nutrition 0.000 claims 4
- 229940043269 zeaxanthin Drugs 0.000 claims 4
- 239000001775 zeaxanthin Substances 0.000 claims 4
- 239000011701 zinc Substances 0.000 claims 4
- 229910052725 zinc Inorganic materials 0.000 claims 4
- 235000016804 zinc Nutrition 0.000 claims 4
- 229930003779 Vitamin B12 Natural products 0.000 claims 2
- 229960002685 biotin Drugs 0.000 claims 2
- 235000020958 biotin Nutrition 0.000 claims 2
- 239000011616 biotin Substances 0.000 claims 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 2
- 239000006071 cream Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims 2
- 235000019163 vitamin B12 Nutrition 0.000 claims 2
- 239000011715 vitamin B12 Substances 0.000 claims 2
- 235000019158 vitamin B6 Nutrition 0.000 claims 2
- 239000011726 vitamin B6 Substances 0.000 claims 2
- 229940011671 vitamin b6 Drugs 0.000 claims 2
- 241001572175 Gaza Species 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000006186 oral dosage form Substances 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- 229940100611 topical cream Drugs 0.000 claims 1
- 229940042129 topical gel Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562180842P | 2015-06-17 | 2015-06-17 | |
| US62/180,842 | 2015-06-17 | ||
| PCT/US2016/037050 WO2016205089A1 (en) | 2015-06-17 | 2016-06-10 | Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020018227A Division JP2020073587A (ja) | 2015-06-17 | 2020-02-05 | ざ瘡の予防および治療のためのタウリンおよびマグネシウムを含む局所用製剤および経口用製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018517787A JP2018517787A (ja) | 2018-07-05 |
| JP2018517787A5 true JP2018517787A5 (enExample) | 2019-06-27 |
| JP6657394B2 JP6657394B2 (ja) | 2020-03-04 |
Family
ID=57546606
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018518567A Expired - Fee Related JP6657394B2 (ja) | 2015-06-17 | 2016-06-10 | ざ瘡の予防および治療のためのタウリンおよびマグネシウムを含む局所用製剤および経口用製剤 |
| JP2020018227A Pending JP2020073587A (ja) | 2015-06-17 | 2020-02-05 | ざ瘡の予防および治療のためのタウリンおよびマグネシウムを含む局所用製剤および経口用製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020018227A Pending JP2020073587A (ja) | 2015-06-17 | 2020-02-05 | ざ瘡の予防および治療のためのタウリンおよびマグネシウムを含む局所用製剤および経口用製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US9795633B2 (enExample) |
| EP (1) | EP3310366A4 (enExample) |
| JP (2) | JP6657394B2 (enExample) |
| KR (2) | KR20190137971A (enExample) |
| CN (1) | CN107708708A (enExample) |
| AU (1) | AU2016278939B2 (enExample) |
| CA (1) | CA2987293C (enExample) |
| MX (1) | MX365366B (enExample) |
| WO (1) | WO2016205089A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9642877B1 (en) * | 2016-01-06 | 2017-05-09 | Kenneth O. Russell | Method of administration of chromium and magnesium sulfate for treatment of acne |
| CA2987293C (en) * | 2015-06-17 | 2020-11-03 | Margaret Jean Profet | Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne |
| CN107049890B (zh) * | 2017-06-27 | 2020-04-03 | 广东芭薇生物科技股份有限公司 | 一种具有舒缓抗粉刺功效的护肤品 |
| KR102310566B1 (ko) * | 2018-05-21 | 2021-10-08 | 랩앤피플주식회사 | 여드름 완화 및 예방용 패치 |
| WO2019225948A1 (ko) * | 2018-05-21 | 2019-11-28 | 랩앤피플주식회사 | 여드름 완화 및 예방용 패치 |
| KR102651395B1 (ko) * | 2018-07-05 | 2024-03-26 | 랩앤피플주식회사 | 여드름 완화 및 예방용 화장품 조성물 |
| EP3738588A1 (en) | 2019-05-13 | 2020-11-18 | Margaret Jean Profet | Topical and oral formulations comprising taurine and magnesium for use in the treatment of rosacea |
| CA3137407A1 (fr) | 2019-05-16 | 2020-11-19 | Synapharm Industrial Synthesis | Compound and composition for use in the treatment of premenstrual syndrome and/or premenstrual dysphoric disorder |
| ES2917623T3 (es) * | 2019-05-16 | 2022-07-11 | Synapharm Ind Synthesis | Compuesto y composición para uso en el tratamiento del síndrome premenstrual y/o del trastorno disfórico premenstrual |
| WO2024118480A1 (en) * | 2022-11-28 | 2024-06-06 | Epiphany Biosciences | Use of antiviral agents, composition of matter, combination preparations/agents to treat chronic diseases associated with epstein-barr virus and other human herpes viruses |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2384751A1 (fr) | 1977-03-23 | 1978-10-20 | Francaise Coop Pharma | Nouveaux derives de la taurine a activite neuro-musculaire renforcee |
| US4545977A (en) | 1985-01-11 | 1985-10-08 | G. D. Searle & Co. | Compositions and methods for treating severe acne with isotretinoin |
| CN1126596A (zh) * | 1995-01-11 | 1996-07-17 | 徐富中 | 一种治疗粉刺的制剂 |
| US5776498A (en) | 1995-11-06 | 1998-07-07 | Nutrition 21 | Magnesium taurate as an adjuvant to rapid thrombolytic therapy |
| US5582839A (en) | 1995-04-18 | 1996-12-10 | Nutrition 21 | Magnesium taurate and other mineral taurates |
| US5962517A (en) | 1997-01-31 | 1999-10-05 | Murad; Howard | Pharmaceutical compositions and methods for treating acne |
| US6558656B2 (en) | 2000-04-20 | 2003-05-06 | Morris Mann | Oral and topical compositions and methods related thereto in the treatment of acne |
| US20040039042A1 (en) | 2002-08-23 | 2004-02-26 | Fleming Thomas E. | Method of transdermal drug delivery |
| US20040214891A1 (en) | 2003-04-22 | 2004-10-28 | Janusz Marcinkiewicz | Method for inhibiting pathogenic bacteria and fungi growth and microbicidal composition |
| US20050008684A1 (en) | 2003-07-10 | 2005-01-13 | Claus Herdeis | Method of treatment for acne, rosacea and ulcers with taurolidine and/or taurultam in a pharmaceutical composition |
| US7258875B2 (en) | 2003-12-04 | 2007-08-21 | Chiou Consulting, Inc. | Compositions and methods for topical treatment of skin infection |
| EP1720515A1 (en) * | 2004-03-02 | 2006-11-15 | GIULIANI S.p.A. | Composition for regulating the trophism of hair follicles and the cutaneous production of sebum and use thereof in androgenetic alopecia |
| US20060193922A1 (en) | 2005-02-25 | 2006-08-31 | Natalia Neikrug | Compositions and methods for the treatment of acne |
| US7955610B2 (en) | 2005-08-04 | 2011-06-07 | National Science And Technology Development Agency | Antimicrobial composition for topical application and a method thereof |
| AR062334A1 (es) | 2006-08-11 | 2008-10-29 | Panacea Biotec Ltd | Particulas para suministrar ingredientes activos, proceso para hacerlas y composiciones de las mismas |
| JP2011528377A (ja) * | 2008-07-17 | 2011-11-17 | レヴィス，ジョージア | 座瘡治療のための方法及び物質 |
| PL2418945T3 (pl) * | 2009-04-15 | 2019-05-31 | Bmg Pharma S P A | Kompozycje soli mineralnej - kwasu sulfonowego i sposoby ich stosowania |
| US20140121188A1 (en) | 2009-10-02 | 2014-05-01 | Foamix Ltd. | Compositions for the improved treatment of acne and related disorders |
| KR20170018852A (ko) * | 2014-07-01 | 2017-02-20 | 엔리케 샤콘 | 상처 치료를 위한 국소 조성물 및 방법 |
| CA2987293C (en) * | 2015-06-17 | 2020-11-03 | Margaret Jean Profet | Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne |
-
2016
- 2016-06-10 CA CA2987293A patent/CA2987293C/en not_active Expired - Fee Related
- 2016-06-10 KR KR1020197036101A patent/KR20190137971A/ko not_active Withdrawn
- 2016-06-10 WO PCT/US2016/037050 patent/WO2016205089A1/en not_active Ceased
- 2016-06-10 AU AU2016278939A patent/AU2016278939B2/en not_active Ceased
- 2016-06-10 EP EP16812186.1A patent/EP3310366A4/en not_active Withdrawn
- 2016-06-10 JP JP2018518567A patent/JP6657394B2/ja not_active Expired - Fee Related
- 2016-06-10 KR KR1020177034741A patent/KR102055492B1/ko not_active Expired - Fee Related
- 2016-06-10 US US15/179,815 patent/US9795633B2/en not_active Expired - Fee Related
- 2016-06-10 MX MX2017015012A patent/MX365366B/es active IP Right Grant
- 2016-06-10 CN CN201680033097.3A patent/CN107708708A/zh active Pending
-
2017
- 2017-10-18 US US15/787,565 patent/US10342823B2/en not_active Expired - Fee Related
-
2020
- 2020-02-05 JP JP2020018227A patent/JP2020073587A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018517787A5 (enExample) | ||
| Schwingshackl et al. | Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: a systematic review and meta-analysis of primary prevention trials | |
| JP6657394B2 (ja) | ざ瘡の予防および治療のためのタウリンおよびマグネシウムを含む局所用製剤および経口用製剤 | |
| CN103533921A (zh) | 用于治疗神经外伤的方法 | |
| JP2017503761A5 (enExample) | ||
| US11129865B2 (en) | NEUPANEX®: neuroprotective, neuroregenerational, and neurogenesis supporting supplement combination | |
| CN105685973B (zh) | 一种肠内营养剂 | |
| RU2015147874A (ru) | Композиция, содержащая комбинацию экстракта бузины и штамма lactobacillus rhamnosus | |
| US20170020834A1 (en) | Prophylactic use of neuroprotectants in sports-related traumatic brain injury | |
| RU2020111305A (ru) | Предупреждение и/или лечение нейродегенеративного заболевания | |
| US8197871B2 (en) | Composition for headache treatment | |
| JP2021505527A5 (enExample) | ||
| EP3024450B1 (en) | Compositions and methods using tiglic aldehyde | |
| JP2023030130A5 (enExample) | ||
| JP2012515783A5 (enExample) | ||
| EP3024448B1 (en) | Compositions and methods using p-anisaldehyde | |
| JP2019532098A5 (enExample) | ||
| JP2018529763A5 (enExample) | ||
| US20220062306A1 (en) | Compounds for prenatal treatment comprisiing a natal vitamin and aspirin and method for making and using the same | |
| CN106714788A (zh) | 药物制剂 | |
| EP3024449B1 (en) | Compositions and methods using cuminaldehyde | |
| US20130316017A1 (en) | Oral Composition for the Treatment of Acne | |
| HRP20151339T1 (hr) | Pripravak baziran na ubidekarenonu | |
| WO2014207317A1 (en) | A pharmaceutically feasible and safe combination for use in the treatment of major diseases | |
| US8889157B1 (en) | Composition for cardiovascular treatment |